Question Bank › Disproportional response

Disproportional response

Disproportional response: a small company's current business is visibly outgrowing its own size

Calls Tested
491
Answered YES
4
Hit Rate
0.8%
rare by design

Calix, Inc. (CALX) — this company's answers

NO on the Q1 2023 call 2023-04-20 C+
The model's full reasoning — Q1 2023 call → NO我们只需要根据提供的文本判断管理层的表述是否传达了公司当前业务相对于公司规模而言过大。关键点:公司是否小,而当前正在发生的业务(订单、客户、活动)相对于这个规模是大的。管理层是否明确表达了这种不成比例。 在文本中,管理层提到“three consecutive years of greater than 25% growth”、“raising annual guidance for 2023”、“nine consecutive quarters of sequential growth”等,但这些都是增长指标,没有明确说公司小。他们提到“landed 11 new BSPs”、“38 BSPs adopted one or both of the Revenue EDGE and the Intelligent Access EDGE”、“41 BSPs began differentiating their offerings”等,但这些都是客户数量,没有与公司规模对比。 管理层提到“This new market is made up of broadband service providers...”,但这是市场描述。他们提到“Calix is alone in a new market”,但这不是关于规模不成比例。 在回答分析师问题时,管理层提到“we're in a new market. It's the beginning of that new market. It's a once in a generation opportunity.” 但这是关于机会,不是关于当前业务相对于公司规模的大小。 管理层提到“we have a growing customer success army”,但也没有对比。 关键点:管理层是否说“what is happening to it now is disproportionately large compared with that smallness”?没有直接说。他们提到“the land and expand nature of our business was on full display in Q1 as we landed 11 new BSPs and expanded platform adoption as 38 BSPs adopted one or both of the Revenue EDGE and the Intelligent Access EDGE.” 但这是正常业务。 在回答关于RPO的问题时,管理层说“contract signings are lumpy”,但没有说相对于公司规模。 在回答关于新客户数量下降时,管理层说“with the rise in interest rates, that has made the hurdle for someone to acquire capital to start a brand new company harder. And so, we noticed that happening in the market for sure.” 但这是关于市场,不是关于公司规模。 管理层提到“we're in a new market”多次,但都是关于市场机会,没有明确说公司小。 在回答关于OpEx时,管理层说“we're going to continue to invest according to our target financial model”,没有对比。 在回答关于现金时,管理层说“we expect we'll start seeing double-digit cash generation”,但这是财务。 没有一处明确说“公司小,而当前业务相对于公司规模大”。管理层只是说增长强劲,但这是普通说法。 因此,答案应为NO。

← Back to the full CALX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup — that is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation: the company is small, and what is happening to it now is disproportionately large compared with that smallness. Any genuine expression of this counts, and the form varies widely across industries. For example — management noting that the business it is winning, booking, or being asked to do is large next to the company's current revenue, footprint, or headcount; that a single customer, contract, program, product, or market now in motion could by itself rival or exceed a meaningful share of today's company; that the company is handling, preparing for, or committing to volumes, projects, or relationships that would have been out of reach for a company of its size until now; that the same absolute wins keep translating into outsized percentage change because the base is still small; or management explicitly contrasting how little the company has captured so far with the scale of what is already reaching it. What matters is the DISPROPORTION, stated or plainly implied by management itself, between the size of the company and the size of what is currently arriving or being committed to it — grounded in real, present-tense business (orders, customers, work, volumes, commitments, or activity happening now), not in market-size statistics, pipelines, or hopes. Answer NO if the company is large relative to what it describes, or already a leading participant with no meaningful disproportion ahead of it. NO if management simply reports strong demand, a good quarter, or healthy growth in the ordinary way without conveying that what is arriving is large relative to the company's own small size. NO if the 'big opportunity' language is a generic total-addressable-market figure, an industry forecast, or promotional talk about a huge market with no reference to how little of it this company has taken or how small the company is against what is already reaching it. NO if the large-scale business described is only prospective — a market not yet entered, an approval or decision still pending, a customer still being pursued, a product still being developed — rather than something already arriving or already committed. NO if the disproportion is described only as a dependency risk or concentration concern management is trying to reduce. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D

How the model reasoned

VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.

More from the question bank

Operating in the future tenseBreak from their own historyThe open question just closedQ&A has flipped from problems to possibilitiSold before it existsCheap-to-serve incremental businessAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.